story of the week
Real-World Evidence on Prescribing Patterns and Clinical Outcomes in Patients With MBC Treated With PARP Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Breast Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience
Clin. Breast Cancer 2024 Oct 17;[EPub Ahead of Print], N Jahan, J Taraba, NJ Boddicker, KV Giridhar, RA Leon-Ferre, AJ Tevaarwerk, E Cathcart-Rake, CC O'Sullivan, PP Peethambaram, TJ Hobday, LA Mina, F Batalini, P Advani, K Sideras, TC Haddad, KJ Ruddy, MP Goetz, FJ Couch, S YadavFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.